| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0961203307078682 |
| P698 | PubMed publication ID | 17664235 |
| P2093 | author name string | Weisman MH | |
| Wallace DJ | |||
| Pressman BD | |||
| Ishimori ML | |||
| P2860 | cites work | A reversible posterior leukoencephalopathy syndrome | Q28273132 |
| Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. | Q30652846 | ||
| MRI and the brain in systemic lupus erythematosus | Q30887269 | ||
| The blood-brain barrier in systemic lupus erythematosus | Q30887274 | ||
| Neuroimaging in posterior reversible encephalopathy syndrome | Q30923275 | ||
| Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus | Q30927033 | ||
| Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed | Q30982510 | ||
| Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus | Q31043862 | ||
| Value of MRI of the brain in patients with systemic lupus erythematosus and neurologic disturbance | Q33195490 | ||
| Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine | Q33369607 | ||
| Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus | Q33562233 | ||
| The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation | Q34669837 | ||
| Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis | Q35550466 | ||
| Endothelium and the brain in CNS lupus | Q35625233 | ||
| Reversible posterior leukoencephalopathy in connective tissue diseases | Q36502432 | ||
| Occipital-parietal encephalopathy: a new name for an old syndrome | Q36852478 | ||
| MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus | Q40406766 | ||
| Serial study of apparent diffusion coefficient and anisotropy in patients with acute stroke | Q40791056 | ||
| Edema of the nephrotic syndrome: the role of the atrial peptide system | Q40846569 | ||
| Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon {alpha}. | Q43048537 | ||
| Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases | Q44049678 | ||
| Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm | Q44292937 | ||
| Tacrolimus leukoencephalopathy: a neuropathologic confirmation | Q45081516 | ||
| Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus | Q46909297 | ||
| Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning | Q48115666 | ||
| Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. | Q48151166 | ||
| Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (PRES). | Q48203203 | ||
| Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. | Q48348700 | ||
| Erythropoietin-associated hypertensive posterior leukoencephalopathy. | Q48625434 | ||
| Reversible posterior leukoencephalopathy syndrome and bevacizumab | Q48631436 | ||
| Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia | Q48717832 | ||
| Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study | Q48724943 | ||
| Neuropsychiatric systemic lupus erythematosus: correlation of brain MR imaging, CT, and SPECT. | Q48911695 | ||
| Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus | Q49021080 | ||
| 31-year-old woman with confusion and labile behavior. | Q51956226 | ||
| P433 | issue | 6 | |
| P921 | main subject | posterior reversible encephalopathy syndrome | Q7234232 |
| P304 | page(s) | 436-443 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? | |
| P478 | volume | 16 |
| Q92278855 | "Highlighting" red nuclei by atypical posterior reversible encephalopathy syndrome in a patient with systemic lupus erythematosus |
| Q46445641 | A case of PRES in an active lupus nephritis patient after treatment of corticosteroid and cyclophosphamide |
| Q50263145 | Age and gender may affect posterior reversible encephalopathy syndrome in renal disease |
| Q43251129 | Central variant of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: new associations? |
| Q36277546 | Chorea as the first and only manifestation of systemic lupus erythematosus |
| Q33407827 | Clinical features and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus |
| Q47226466 | Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study. |
| Q34995019 | Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report |
| Q47899551 | Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome |
| Q42712084 | Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome. |
| Q48325919 | MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus |
| Q36971681 | Posterior Reversible Encephalopathy Syndrome in Henoch-Schonlein Purpura and Hemolytic Uremic Syndrome |
| Q31078775 | Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus |
| Q34503053 | Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus |
| Q31145483 | Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature |
| Q38448773 | Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome |
| Q45958416 | Posterior reversible encephalopathy syndrome posttransplantation: a case report of possible association with cerebrospinal fluid leak after epidural catheterization. |
| Q46512652 | Reversible posterior leukoencephalopathy syndrome in a patient with Takayasu arteritis |
| Q85214464 | Strategic Involvement of Facial Colliculus in SLE |
| Q33420286 | Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report |
| Q47606458 | The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients |
Search more.